On the 17th, the US FDA = Food and Drug Administration held a committee of external experts to verify the efficacy and safety of the new coronavirus vaccine of the pharmaceutical company Moderna, and the committee said, "The benefits of vaccination outweigh the risks. I have summarized the conclusion.
Following this conclusion, the FDA is expected to promptly decide to permit emergency use of this vaccine in the future.
Moderna, an American pharmaceutical company, applied to the FDA for an emergency use of the new coronavirus vaccine last month and is being reviewed.
On the 17th, the FDA held a committee to hear from outside experts about the vaccine.
After a detailed review of the efficacy and health impact data presented by the FDA and Moderna, the committee voted and said, "On scientific grounds, people over the age of 18 will be vaccinated with this vaccine. The benefits of doing so outweigh the risks, "the majority agreed.
It encourages the FDA to grant permission for emergency use of this vaccine, and the FDA is expected to promptly decide on permission in the future.
It will be the second case in the United States after the vaccine developed by the pharmaceutical giant Pfizer and the German company Biontech if it is approved for emergency use.
The U.S. government's vaccine supply plan manager said that if Moderna's vaccine was approved for emergency use, it would ship 5.9 million doses at the beginning of the week and could supply 20 million doses by the end of this month.